Table 2

Comparison of (A) recurrence-free, (B) survival and (C) extrahepatic recurrence between Huaier and control groups

Huaier (n=686)Control (n=316)
(A) Recurrence
 Recurrence-free, n (%)428 (62.39)155 (49.05)
 Recurrence, n (%)258 (37.61)161 (50.56)
 CMH-χ2 14.7315
 P value0.0001
 Difference, 95% CI13.34 (6.74 to 19.94)
(B) Survival
 Survival, n (%)653 (95.18)289 (91.46)
 Death, n (%)33 (4.81)27 (8.54)
  CMH-χ2 5.3524
 P value0.0207
Difference, 95% CI3.73 (0.26 to 7.21)
(C) Extrahepatic recurrence
 No extrahepatic recurrence, n(%)627 (91.40)273 (86.39)
 Extrahepatic recurrence, n(%)59 (8.60)43 (13.61)
 CMH-χ2 5.9260
 P value0.0149
 Difference, 95% CI−7.55 (–12.59 to –2.50)
  • CMH, Cochran-Mantel-Haenszel test.